B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Clinical trials for B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New hope for kids with Tough-to-Treat leukemia

Disease control Ongoing

This study is testing a drug called blinatumomab in Chinese children whose B-cell acute lymphoblastic leukemia (B-ALL) has come back or hasn't responded to other treatments. The main goal is to see if the drug can put the cancer into remission. Researchers will also closely monit…

Matched conditions: B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Get alerted when new B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

New hope for kids with Tough-to-Treat leukemia